Cannaisseur Group Inc. (TCRG) intrinsic value & 10-year financials

Cannaisseur Group Inc. (TCRG) has a Graham intrinsic value of $4.50 per share. Over the last 5 fiscal years revenue shrank 91.1% a year to $0, with an average return on invested capital of 583.3%.

Graham intrinsic value
$4.50
Revenue (FY2025)
$0
Revenue growth (5-yr CAGR)
-91.1%
ROIC (10-yr avg)
583.3%
Free cash flow (FY2025)
—

TCRG 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $0 -$1.8M -$0.03 — — 595.1%
FY2024 $700 -$1.3M -$0.03 — -180939.9% 1304.4%
FY2023 $53.1K -$128.0K $0.00 — -357.4% 255.5%
FY2022 $88.1K -$80.1K $0.00 — -104.3% 178.3%
FY2021 — — — — — —

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

Cannaisseur Group Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.

Cannaisseur Group Inc. has historically struggled to out-earn its cost of capital, averaging just 5.8% ROIC.

Cannaisseur Group Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, Cannaisseur Group Inc. is modeled at -91.1% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $4.50 per share.

TCRG stock: frequently asked questions

What is the intrinsic value of Cannaisseur Group Inc. (TCRG) stock?

Using Benjamin Graham's revised formula, V = EPS × (8.5 + 2g) × 4.4 / Y, with reported diluted earnings per share, a -91.1% normalized growth rate (capped at 15%) and a 5.1% AAA corporate bond yield, TCRG's intrinsic value is about $4.50 per share.

What is TCRG's return on invested capital?

Average ROIC over the last 5 fiscal years was 583.3%, and average return on equity was 386.1%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this TCRG data come from?

From Cannaisseur Group Inc.'s annual 10-K filings on SEC EDGAR, most recently filed May 11, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar medicinal chemicals & botanical products stocks